X

Trial Profile

A Phase Ib/IIa Pilot Scale Efficacy Study of SON-081 in Diabetic Peripheral Neuropathy (DPN)

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 07 May 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interleukin-6 (Primary)
Indications Diabetic neuropathies
Focus Therapeutic Use
Sponsors New Life Therapeutics

Most Recent Events

03 May 2021 According to a Sonnet BioTherapeutics Holdings media release, the company plans to submit an IND for this study which is expected to commence during the second half of 2021.
12 Aug 2020 New trial record
04 Aug 2020 According to a Sonnet BioTherapeutics Holdings, New Life Therapeutics New Life Therapeutics will be responsible for conducting this trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com